A Mammalian Target of Rapamycin Perilipin 3 (mTORC1-Plin3) Pathway
is essential to Activate Lipophagy and
Protects Against Hepatosteatosis
Marina Garcia-Macia et al
NAFLD is the most common hepatic pathology in western countries and no treatment is currently available. NAFLD is characterized by the aberrant hepatocellular accumulation of fatty acids in the form of lipid droplets (LDs). Recently, it was shown that liver LD degradation occurs through a process termed lipophagy, a form of autophagy. However, the molecular mechanisms governing liver lipophagy are elusive. Here, we aimed to ascertain the key molecular players that regulate hepatic lipophagy and their importance in NAFLD.